2. Epigenetics Cell Cycle/DNA Damage Apoptosis
  3. HDAC CDK Apoptosis
  4. CDK/HDAC-IN-2

CDK/HDAC-IN-2 是一种有效的 HDAC/CDK 双重抑制剂，对于 HDAC1, HDAC2, HDAC3, HDAC6,8, CDK1, CDK2, CDK4,6,7, IC50 分别为 6.4, 0.25, 45, >1000, 8.63, 0.30, >1000 nM。CDK/HDAC-IN-2 显示出优异的抗增殖活性。CDK/HDAC-IN-2 诱导细胞凋亡 (apoptosis) 和细胞周期停滞在 G2/M 期。CDK/HDAC-IN-2 显示出强大的抗肿瘤功效。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

CDK/HDAC-IN-2 Chemical Structure

CDK/HDAC-IN-2 Chemical Structure

CAS No. : 2580938-58-3

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

CDK/HDAC-IN-2 相关抗体

Top Publications Citing Use of Products

查看 HDAC 亚型特异性产品:

查看所有亚型
HDAC HDAC1 HDAC2 HDAC3 HDAC4 HDAC5 HDAC6 HDAC7 HDAC8 HDAC9 HDAC10 HDAC11 HD1 HD2

查看 CDK 亚型特异性产品:

查看所有亚型
CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

CDK/HDAC-IN-2 is a potent HDAC/CDK dual inhibitor with IC50 of 6.4, 0.25, 45, >1000, 8.63, 0.30, >1000 nM for HDAC1, HDAC2, HDAC3, HDAC6,8, CDK1, CDK2, CDK4,6,7, respectively. CDK/HDAC-IN-2 shows excellent antiproliferative activities. CDK/HDAC-IN-2 induces apoptosis and cell cycle arrest at G2/M phase. CDK/HDAC-IN-2 shows potent antitumor efficacy[1].

IC50 & Target[1]

HDAC1

6.4 nM (IC50)

HDAC2

0.25 nM (IC50)

HDAC3

45 nM (IC50)

HDAC6

>1000 nM (IC50)

HDAC8

>1000 nM (IC50)

CDK1

8.63 nM (IC50)

CDK2

0.30 μM (IC50)

CDK4

>1000 nM (IC50)

CDK6

>1000 nM (IC50)

CDK7

>1000 nM (IC50)

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A-375 IC50
1.2 μM
Compound: 7c
Antiproliferative activity against human A375 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human A375 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
[PMID: 31991336]
HCT-116 IC50
0.71 μM
Compound: 7c
Antiproliferative activity against human HCT116 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human HCT116 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
[PMID: 31991336]
HeLa IC50
1.83 μM
Compound: 7c
Antiproliferative activity against human Hela cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human Hela cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
[PMID: 31991336]
NCI-H460 IC50
4.19 μM
Compound: 7c
Antiproliferative activity against human H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
[PMID: 31991336]
SMMC-7721 IC50
7.76 μM
Compound: 7c
Antiproliferative activity against human SMMC7721 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human SMMC7721 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay
[PMID: 31991336]
体外研究
(In Vitro)

CDK/HDAC-IN-2 (compound 7c) shows antiproliferative activity with IC50s of 0.71, 1.20, 1.83, 4.19, 7.76, 4.47 µM for HCT116, A375, Hela, H460, SMMC7721, NIH 3T3 cells, respectively[1].
CDK/HDAC-IN-2 (24 h) shows anti-migration ability in A375 and H460 cells[1].
CDK/HDAC-IN-2 (0.5, 1, 2 µM) induces apoptosis and cell cycle arrest at G2/M phase[1].
CDK/HDAC-IN-2 accelerates intracellular ROS accumulation, leading to cancer cell death[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

CDK/HDAC-IN-2 相关抗体:

Cell Cycle Analysis[1]

Cell Line: A375, HCT116, H460, Hela cells
Concentration: 0.5, 1, 2 µM
Incubation Time: 24 h
Result: Induced cell cycle arrest at G2/M phase.

Apoptosis Analysis[1]

Cell Line: A375, HCT116, H460, Hela cells
Concentration: 0.5, 1, 2 µM
Incubation Time: 48 h
Result: Induced cell apoptosis with the apoptosis rates of A375, HCT116 cells of 97.22%, 60.6%, respectively.
体内研究
(In Vivo)

CDK/HDAC-IN-2 (12.5, 25 mg/kg; IP; once daily for 21 days) shows antitumor efficacy in the HCT116 xenograft model (TGI= 51.0%)[1].
Pharmacokinetic Parameters of CDK/HDAC-IN-2 in ICR male mice[1].

compound 7c
Dose (mg/kg) 20
administration i.p.
t1/2 (h) 2.61
Tmax (h) 2.00
Cmax (h) 7570
AUC0-∞ (ng h/mL) 30700
MRT0-∞ (ng h/mL) 3.31
F (%) 63.6
ICR male mice; 20 mg/kg, i.p.[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: ICR male mice[1]
Dosage: 20 mg/kg
Administration: IP
Result: Showed good Pharmacokinetic parameters with bioavailability of F= 63.6%.
Animal Model: 5-6 weeks, BALB/c female mice (HCT116 xenograft nude mice models)[1]
Dosage: 12.5, 25 mg/kg
Administration: IP, once daily for 21 days
Result: Effectively inhibited the growth of HCT116 xenograft tumors tumor growth inhibitions (TGI) at 12.5 and 25 mg/kg of 37.0% and 51.0%, respectively.
分子量

523.37

Formula

C25H20Cl2N6O3
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

CDK/HDAC-IN-2 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CDK/HDAC-IN-22580938-58-3HDACCDKApoptosisHistone deacetylasesCyclin dependent kinaseantiproliferativeantitumorG2/M phaseapoptosisHCT116 xenograft modelA375HCT116H460Hela cellsInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
CDK/HDAC-IN-2
目录号：
HY-146276
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z